art_12__para_4

Regulation (EU) 2022/2371 of the European Parliament and of the Council of 23 November 2022 on serious cross-border threats to health and repealing Decision No 1082/2013/EU (Text with EEA relevance) · European Union

4. The Commission shall, in liaison with the Member States, ensure coordination and the exchange of information between the entities organising and participating in any action, including, but not limited to, joint procurement procedures for and development, stockpiling, distribution and donation of medical countermeasures, under different mechanisms established at Union level, in particular under: stockpiling under rescEU referred to in Article 12 of Decision No 1313/2013/EU; Regulation (EU) 2016/369; the Pharmaceutical Strategy for Europe; the EU4Health Programme established by Regulation (EU) 2021/522; Regulation (EU) 2021/697 of the European Parliament and of the Council (34); and other programmes and instruments supporting biomedical research and development at Union level for enhanced capacity and readiness to respond to cross-border threats and emergencies, such as measures adopted under Regulation (EU) 2022/2372.

← e) · All articles · a) →

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.